These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12557720)

  • 21. [Phase I study of gemcitabine (GEM) and docetaxel (TXT) combination chemotherapy for unresectable non-small-cell lung cancer].
    Terao I
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1929-33. PubMed ID: 12465392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained complete remission in a patient with platinum-resistant ovarian yolk sac tumor.
    Jeyakumar A; Chalas E; Hindenburg A
    Gynecol Oncol; 2001 Sep; 82(3):578-80. PubMed ID: 11520160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: a trial of the Eastern Cooperative Oncology Group.
    Dreicer R; Manola J; Schneider DJ; Schwerkoske JF; George CS; Roth BJ; Wilding G;
    Cancer; 2003 Jun; 97(11):2743-7. PubMed ID: 12767086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.
    Chen YM; Perng RP; Lin WC; Wu HW; Tsai CM; Whang-Peng J
    Am J Clin Oncol; 2002 Oct; 25(5):509-12. PubMed ID: 12393994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage chemotherapy with the gemcitabine/docetaxel combination in non-small cell lung cancer: an overview of recent phase II studies.
    Kosmas C; Tsavaris N; Kalofonos HP
    Med Sci Monit; 2002 Jun; 8(6):PI58-63. PubMed ID: 12070450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma.
    Popa IE; Stewart K; Smith FP; Rizvi NA
    Cancer; 2002 Oct; 95(8):1714-9. PubMed ID: 12365019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of docetaxel-resistant lung cancer effectively treated with chemotherapy of gemcitabine and vinorelbine].
    Daido K; Arita K; Ohashi N; Nakamura K
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1747-50. PubMed ID: 11057328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial.
    Pectasides D; Glotsos J; Bountouroglou N; Kouloubinis A; Mitakidis N; Karvounis N; Ziras N; Athanassiou A
    Ann Oncol; 2002 Feb; 13(2):243-50. PubMed ID: 11886001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.
    Hainsworth JD; Burris HA; Greco FA
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):21-5. PubMed ID: 11441411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docetaxel (Taxotere) and gemcitabine in combination therapy.
    Rizvi NA
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):19-22. PubMed ID: 10458206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Efficacy of Low-Dose Paclitaxel Added to Combination Chemotherapy of Carboplatin and Gemcitabine or Pegylated Liposomal Doxorubicin.
    Nagao S; Iwasa N; Kurosaki A; Nishikawa T; Hanaoka T; Hasegawa K; Fujiwara K
    Int J Gynecol Cancer; 2016 Mar; 26(3):443-8. PubMed ID: 26807640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docetaxel and gemcitabine combinations in non-small cell lung cancer.
    Rizvi NA; Spiridonidis CH; Davis TH; Bhargava P; Marshall JL; Dahut W; Figuera M; Hawkins MJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):27-31; discussion 41-2. PubMed ID: 10585006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer.
    Georgoulias VA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):18-24. PubMed ID: 11252884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor.
    Hejna M; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger WC; Marosi L; Schneeweiss B; Greul R; Scheithauer W
    Cancer; 2000 Aug; 89(3):516-22. PubMed ID: 10931450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
    Brugnatelli S; Danova M; De Bella MT; Vaglica M; Manuguerra G; Riccardi A; Palmeri S
    Oncology; 2002; 62(1):33-8. PubMed ID: 11810041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I trial of docetaxel and gemcitabine in patients with advanced cancer.
    Rischin D; Boyer M; Smith J; Millward M; Michael M; Bishop J; Zalcberg J; Davison J; Emmett E; McClure B
    Ann Oncol; 2000 Apr; 11(4):421-6. PubMed ID: 10847460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.
    Rebattu P; Quantin X; Ardiet C; Morere JF; Azarian MR; Schuller-Lebeau MP; Pujol JL
    Lung Cancer; 2001; 33(2-3):277-87. PubMed ID: 11551423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
    Georgoulias V; Kouroussis C; Androulakis N; Kakolyris S; Dimopoulos MA; Papadakis E; Bouros D; Apostolopoulou F; Papadimitriou C; Agelidou A; Hatzakis K; Kalbakis K; Kotsakis A; Vardakis N; Vlachonicolis J
    J Clin Oncol; 1999 Mar; 17(3):914-20. PubMed ID: 10071284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer.
    Georgoulias V; Scagliotti G; Miller V; Eckardt J; Douillard JY; Manegold C
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):15-21. PubMed ID: 11284620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.